Human Excitatory amino acid transporter 5 (SLC1A7) ELISA Kit

Category: Assay Kits
Catalog
AE19076HU
(Ships in 5-10 business days)

Questions? Contact us

Call (800) 832-2611

arp-guarantee
- +
$0.00
More Information
Product Name Human Excitatory amino acid transporter 5 (SLC1A7) ELISA Kit
Description EAAT5-mediated L-glutamate uptake was sodium- and voltage-dependent and chloride-independent. Transporter currents elicited by glutamate were also sodium- and voltage-dependent, but ion substitution experiments suggested that this current was largely carried by chloride ions.Although EAAT5 shares the structural homologies of the EAAT family, 1 novel feature of the EAAT5 sequence is a C-terminal motif previously identified in N-methyl-D-aspartate receptors and potassium channels and shown to confer interactions with a family of synaptic proteins that promote ion channel clustering. EAAT5 has 46% amino acid sequence identity with EAAT1 (SLC1A3), 43% identity with EAAT4 (SLC1A6), 37% identity with EAAT3 (SLC1A1), and 36% identity with EAAT2 (SLC1A2). This assay has high sensitivity and excellent specificity for detection of Human SLC1A7. No significant cross-reactivity or interference between Human SLC1A7 and analogues was observed.
Synonyms AAAT, EAAT5, FLJ36602, excitatory amino acid transporter 5 (retinal glutamate transporter)
Method Sandwich ELISA
Detection Range 0.312-20 ng/mL
Sensitivity 0.122 ng/mL
Reactivity Human
Sample Types Serum, Plasma, Other biological fluids.
Background EAAT5-mediated L-glutamate uptake was sodium- and voltage-dependent and chloride-independent. Transporter currents elicited by glutamate were also sodium- and voltage-dependent, but ion substitution experiments suggested that this current was largely carried by chloride ions.Although EAAT5 shares the structural homologies of the EAAT family, 1 novel feature of the EAAT5 sequence is a C-terminal motif previously identified in N-methyl-D-aspartate receptors and potassium channels and shown to confer interactions with a family of synaptic proteins that promote ion channel clustering. EAAT5 has 46% amino acid sequence identity with EAAT1 (SLC1A3), 43% identity with EAAT4 (SLC1A6), 37% identity with EAAT3 (SLC1A1), and 36% identity with EAAT2 (SLC1A2).
Supplier Abebio

All Research Products are sold for laboratory RESEARCH USE ONLY and ARE NOT TO BE USED FOR HUMAN OR ANIMAL THERAPEUTIC OR DIAGNOSTIC APPLICATIONS. The information presented is believed to be accurate; however, said information and products are offered without warranty or guarantee since the ultimate conditions of use and the variability of the materials treated are beyond our control. Nothing disclosed herein is to be construed as a recommendation to use our products in violation of any patents. ARP American Research Products, Inc. does not submit its products for regulatory review by any government body or other organization, and we do not validate them for clinical, therapeutic or diagnostic use, or for safety and effectiveness. You are solely responsible for making sure that the way you use the products complies with applicable laws, regulations and governmental policies and for obtaining all necessary approvals, intellectual property rights, licenses and permissions that you may need related to your use. Under no circumstances shall ARP American Research Products, Inc. be liable for damages, whether consequential, compensatory, incidental or special, strict liability or negligence, breach of warranty or any other theory arising out of the use of the products available from ARP American Research Products, Inc. Nothing contained herein warrants that the use of the products will not infringe on the claims of any patents covering the product itself or the use thereof in combination with other products or in the operation of any process. ARP American Research Products, Inc. disclaims any and all representations or warranties of any kind whatsoever, express or implied, including without limitation any implied warranties of merchantability or fitness for a particular purpose, of non-infringement, or regarding results obtained through the use of any product, whether arising from a statute or otherwise in law or from a course of performance, dealing or usage of trade.